One of the main pillars of Prohealth is the Pharma Division. Since its inception in 1995, Prohealth has built a strong portfolio of European pharmaceutical companies offering branded, prescription, and OTC products that includes Ursapharm, Galderma, PIAM, Italchimici, Rowa, Laboratori Plants, Discovery, ICB, Natiris, and Azevedos.
Prohealth is entrusted with the registration, importation, marketing, and distribution of the products of its parent pharmaceutical companies in Malta. Such a process necessitates a high level of expertise in each field combined with excellent teamwork between the regulatory affairs, logistic, medical representatives, and pharmacy sales teams within this fast-growing division.
Success with such an extensive portfolio requires professional and ethical, yet consistent medical detailing of the highest level to a wide variety of medical specialists that include Ophthalmologists, Paediatricians, Family Doctors, Surgeons, Respiratory Physicians, ENT specialists, Psychiatrists, Geriatricians, Orthopaedic Surgeons, Gastroenterologists and Infectious Disease Physicians, to name a few. Interaction with pharmacists and other healthcare professionals, such as nurses and mid-wives is equally important to ensure optimal standards of care and consequential high patient satisfaction at all times. The Pharma Division’s experienced and qualified team of medical representatives is today very well-structured to meet the numerous challenges that lie ahead in this fast-changing marketplace.
In late 2009 Prohealth’s Pharma Division successfully launched Ursapharm products in Libya, and following the positive results obtained, it has recently been entrusted with the introduction of Ursapharm in other developing African markets.